AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
SAFETY AND TOLERABILITY OF THE FREE-RADICAL SCAVENGER OPC-14117 IN HUNTINGTONS-DISEASE
Authors: SHOULSON I PENNEY J KIEBURTZ K OAKES D CHASE T CHOI D MARDER K MOSKOWITZ C ZUBIN N VENTURA P FEIGIN A HICKEY C COMO P RICHARD IH GOLDSTEIN J HERSCH S BISSEYBLACK C JONES R SWENSON M BELL J PAULSEN JS SWENSON A TAWFIKREEDY Z ORME C PLUMB S RUDOLPH A CLAUDE K MCMULLEN N DAY D MARSHALL FJ BOURGEOIS K WATTS A TARIOT PN JACKSON WJ HALL WJ MADDREY W BIZIERE K JAFFE M
Citation: I. Shoulson et al., SAFETY AND TOLERABILITY OF THE FREE-RADICAL SCAVENGER OPC-14117 IN HUNTINGTONS-DISEASE, Neurology, 50(5), 1998, pp. 1366-1373
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DEPRENYL AND THIOCTIC ACID IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED COGNITIVE IMPAIRMENT
Authors: SACKTOR N KIEBURTZ K SCHIFITTO G MCDERMOTT M BOURGEOIS K PALUMBO D ORME C ZIMMERMAN C GELBARD H HICKEY C CASACELI C GUTHRIE B RUMFOLA L PLUMB S RUDOLPH A KAMP C EPSTEIN L MARDER K ALBERT S DOONEIEF G STERN Y TODAK G FRIEDMANCLOUSE R POLANCO C WINSTON T MAYEUX R SACKTOR N SELNES O HASENAUER D ESPOSITO D NANCESPROSON L MCARTHUR J OSULLIVAN J SHOULSON I OAKES D REICHMAN R
Citation: N. Sacktor et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DEPRENYL AND THIOCTIC ACID IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED COGNITIVE IMPAIRMENT, Neurology, 50(3), 1998, pp. 645-651
ENTACAPONE IMPROVES MOTOR FLUCTUATIONS IN LEVODOPA-TREATED PARKINSONS-DISEASE PATIENTS
Authors: KIEBURTZ K SHOULSON I FAHN S MCDERMOTT M KOLLER W LEWITT P NUTT J KURTH M BREWER M LEW M WELSH M WATERS C BENNETT J ROSTRUFFNER E FEIGIN A GARDINER I KURLAN R HAMMERSTAD J STONE C JANKOVIC J BEACH J TETRUD J KELKER K STANDAERT DG GROWDON JH TENNIS M GRAEFE K MARK MH KELLY SJ PAHWA R MCGUIRE D HUBBLE J FACTOR SA BROWN DL TUITE P SIME E LANG DL GREENE P WINFIELD H PAULSON G ZOOG K WEEKS C SHULTS C FONTAINE D JUNCOS JL WOOD C SHANNON K JAGLIN JA TORNABENE J LANNON MC DAVIES R FRIEDMAN J TARIOT PN HALL WJ HERNDON R PFEIFFER RF PLUMB S CASACELI C RANDOLPH H BEHMAN H CONNORTON J DAY D RUDOLPH A PELUSIO R GUTHRIE B CLAUDE K ORME C BAKER D NOBEL R IRVINE C WATTS A GORDIN A HEIKKINEN H RITA H
Citation: K. Kieburtz et al., ENTACAPONE IMPROVES MOTOR FLUCTUATIONS IN LEVODOPA-TREATED PARKINSONS-DISEASE PATIENTS, Annals of neurology, 42(5), 1997, pp. 747-755
SURFACE EVOLUTION DURING MBE GROWTH
Authors: ORME C ORR BG
Citation: C. Orme et Bg. Orr, SURFACE EVOLUTION DURING MBE GROWTH, Surface review and letters, 4(1), 1997, pp. 71-105
SAFETY AND TOLERABILITY OF THE ANTIOXIDANT OPC-14117 IN HIV-ASSOCIATED COGNITIVE IMPAIRMENT
Authors: KIEBURTZ K SCHIFITTO G MCDERMOTT M HEO M IRVINE C PALUMBO D ORME C ZIMMERMAN C GELBARD H HICKEY C CASACELI C GUTHRIE B RUMFOLA L EPSTEIN L MARDER K RAMACHANDRAN G ALBERT S DOONEIEF G STERN Y TODAK G FRIEDMANCLOUSE R POLANCO C WINSTON T MAYEUX R DALPAN G SELNES O SACKTOR N HASENAUER D ESPOSITO D NANCESPROSON L MCARTHUR JC SHOULSON I OAKES D REICHMAN R OSULLIVAN J
Citation: K. Kieburtz et al., SAFETY AND TOLERABILITY OF THE ANTIOXIDANT OPC-14117 IN HIV-ASSOCIATED COGNITIVE IMPAIRMENT, Neurology, 49(1), 1997, pp. 142-146
GLUCOSE-INDUCED PROTEIN-KINASE-C ACTIVATION REGULATES VASCULAR-PERMEABILITY FACTOR MESSENGER-RNA EXPRESSION AND PEPTIDE PRODUCTION BY HUMANVASCULAR SMOOTH-MUSCLE CELLS IN-VITRO
Authors: WILLIAMS B GALLACHER B PATEL H ORME C
Citation: B. Williams et al., GLUCOSE-INDUCED PROTEIN-KINASE-C ACTIVATION REGULATES VASCULAR-PERMEABILITY FACTOR MESSENGER-RNA EXPRESSION AND PEPTIDE PRODUCTION BY HUMANVASCULAR SMOOTH-MUSCLE CELLS IN-VITRO, Diabetes, 46(9), 1997, pp. 1497-1503
A CONTROLLED TRIAL OF REMACEMIDE HYDROCHLORIDE IN HUNTINGTONS-DISEASE
Authors: KIEBURTZ K FEIGIN A MCDERMOTT M COMO P ABWENDER D ZIMMERMAN C HICKEY C ORME C CLAUDE K SOTACK J GREENAMYRE JT DUNN C SHOULSON I
Citation: K. Kieburtz et al., A CONTROLLED TRIAL OF REMACEMIDE HYDROCHLORIDE IN HUNTINGTONS-DISEASE, Movement disorders, 11(3), 1996, pp. 273-277
UNIFIED HUNTINGTONS-DISEASE RATING-SCALE - RELIABILITY AND CONSISTENCY
Authors: KIEBURTZ K PENNEY JB COMO P RANEN N SHOULSON I FEIGIN A ABWENDER D GREENAMYRE JT HIGGINS D MARSHALL FJ GOLDSTEIN J STEINBERG K SHIH C RICHARD I HICKEY C ZIMMERMAN C ORME C CLAUDE K OAKES D SAX DS KIM A HERSCH S JONES R AUCHUS A OLSEN D BISSEYBLACK C RUBIN A SCHWARTZ R DUBINSKY R MALLONEE W GRAY C GODFREY N SUTER G SHANNON KM STEBBINS GT JAGLIN JA MARDER K TAYLOR S LOUIS E MOSKOWITZ C THORNE D ZUBIN N WEXLER N SWENSON MR PAULSEN J SWERDLOW N ALBIN R WERNETTE C WALKER F HUNT V ROOS RAC YOUNG AB KOROSHETZ W BIRD E MEYERS R CUDKOWICZ M GUTTMAN M STCYR J BURKHOLDER J LUNDIN A ASHIZAWA T JANKOVIC J SIEMERS E QUAID K MARTIN W SANCHEZRAMOS J FACCA A REY G SUCHOWERSKY O ROHS G KLINEK ML ROSS C BYLSMA FW SHERR M HAYDEN M RAYMOND L CLARK C KREMER B
Citation: K. Kieburtz et al., UNIFIED HUNTINGTONS-DISEASE RATING-SCALE - RELIABILITY AND CONSISTENCY, Movement disorders, 11(2), 1996, pp. 136-142
EFFECT OF LAZABEMIDE ON THE PROGRESSION OF DISABILITY IN EARLY PARKINSONS-DISEASE
Authors: KIEBURTZ K MCDERMOTT M SHOULSON I FAHN S BRIN M GOETZ C LANG A OLANOW CW LEWITT P MISTURA K WATERS C WELSH M RODNITZKY R DOBSON J ARGATOFF P TANNER C LEWIS P WATTS R BRYAN B COMELLA C JAGLIN JA SHULTS C FONTAINE D BRESSMAN SB MOSKOWITZ C HURTIG HI SHALLOW K HUBBLE J BARTER R BENNETT JP ROSTRUFFNER E PERLMUTTER JS MCGEEMINNICH L HAUSER R GAUGER L RAJPUT AH SUTTON A TRINIDAD K GARDINER IF SINGER C SHELDON C FINK JS TENNIS M BAKER D BOURGEOIS K CASACELI C CLAUDE K HICKEY G NOBEL R OAKES D ORME C PELUSIO RM PLUMB S RUDOLPH A RANDOLPH P SOTACK J WATTS A TARIOT PN GOLBE LI MILLER P HALL WJ HERNDON R DORFLINGER E MYL D MODI M OARSLEY L YOO K ELIAHOU E SHIMOUN G COLLETTA S SIEGEL J PEDDER S DUPUIS D
Citation: K. Kieburtz et al., EFFECT OF LAZABEMIDE ON THE PROGRESSION OF DISABILITY IN EARLY PARKINSONS-DISEASE, Annals of neurology, 40(1), 1996, pp. 99-107
IMPACT OF DEPRENYL AND TOCOPHEROL TREATMENT ON PARKINSONS-DISEASE IN DATATOP SUBJECTS NOT REQUIRING LEVODOPA
Authors: SHOULSON I FAHN S OAKES D LANG A LANGSTON JW LEWITT P OLANOW CW PENNEY JB TANNER C KIEBURTZ K KOLLER W RODNITZKY R FINK JS GROWDON JH PAULSON G KURLAN R FRIEDMAN JH GANCHER S NUTT J RAJPUT AH BENNETT JB WOOTEN GF GOETZ C SHANNON K SUCHOWERSKY O BRIN MF BRESSMAN SB WEINER WJ SANCHEZRAMOS J JANKOVIC J HOEHN M TETRUD J GRIMES JD PFEIFFER R SHULTS C THAL L GAUTHIER S GOLBE LI PERLMUTTER JS MOSES H REICH SG HURTIG HI STERN M BARTER R VETEREOVERFIELD B GAUGER L MALAPIRA T DOBSON J ATAMIAN S TENNIS M COHEN JB DESCLOS G HOFFMAN E DENIO L HUBER S WOIKE T ZOOG K MENDELL R DUDTE K BEHR J GARDINER IF LANNON M CARTER J NORTHRUP S KANIGAN B TURK M LANDOW E SCHLICK P MISTURA K CARROLL VS THELEN JA DEMONG C WINFIELD L MOSKOWITZ C INGENITO A SHELDON C CORNELIUS L HEIBERG D DUNNE C BRADY J KIERANS C BELLESCANTLEBURY L DUFF J WEBER H SAVOINI D LEWIS P KUTNER SJ GRAY P GLAESKE C HOFMAN R PAY MM SALMON D MCFAUL F AMYOT D BERGEN M MCGEEMINNICH L ODONNELL P FERRISE S SHALLOW K BAKER D CASACELI C EBERLY S MCDERMOTT M NOBEL R ORME C PELUSIO RM PLUMB S RUDOLPH A RANDOLPH H SOTACK J WATTS A
Citation: I. Shoulson et al., IMPACT OF DEPRENYL AND TOCOPHEROL TREATMENT ON PARKINSONS-DISEASE IN DATATOP SUBJECTS NOT REQUIRING LEVODOPA, Annals of neurology, 39(1), 1996, pp. 29-36
THE POTENTIAL FOR ENDOGENEITY BIAS IN DATA ENVELOPMENT ANALYSIS
Authors: ORME C SMITH P
Citation: C. Orme et P. Smith, THE POTENTIAL FOR ENDOGENEITY BIAS IN DATA ENVELOPMENT ANALYSIS, The Journal of the Operational Research Society, 47(1), 1996, pp. 73-83
CLINICAL CONFIRMATION OF THE AMERICAN-ACADEMY-OF-NEUROLOGY ALGORITHM FOR HIV-ASSOCIATED COGNITIVE MOTOR DISORDER/
Authors: MARDER K ALBERT S DOONEIEF G STERN Y RAMACHANDRAN G TODAK G FRIEDMANCLOUSE R POLANCO C WINSTON T SCHOFIELD P MAYEUX R PAN GD SELNES O SACKTOR N HASENAUER D ESPOSITO D NANCESPROSON L MCARTHUR J KIEBURTZ K SCHIFITTO G MCDERMOTT M PALUMBO D ORME C ZIMMERMAN C GELBARD H HICKEY C CASACELI C GUTHRIE B RUMFOLA L EPSTEIN L
Citation: K. Marder et al., CLINICAL CONFIRMATION OF THE AMERICAN-ACADEMY-OF-NEUROLOGY ALGORITHM FOR HIV-ASSOCIATED COGNITIVE MOTOR DISORDER/, Neurology, 47(5), 1996, pp. 1247-1253
ATOMIC-FORCE MICROSCOPY AND SCANNING-TUNNELING-MICROSCOPY STUDIES OF LARGE-SCALE UNSTABLE GROWTH FORMED DURING GAAS(001) HOMOEPITAXY
Authors: ORME C JOHNSON MD LEUNG KT ORR BG
Citation: C. Orme et al., ATOMIC-FORCE MICROSCOPY AND SCANNING-TUNNELING-MICROSCOPY STUDIES OF LARGE-SCALE UNSTABLE GROWTH FORMED DURING GAAS(001) HOMOEPITAXY, Materials science & engineering. B, Solid-state materials for advanced technology, 30(2-3), 1995, pp. 143-148
FUNCTIONAL DECLINE IN HUNTINGTONS-DISEASE
Authors: FEIGIN A KIEBURTZ K BORDWELL K COMO P STEINBERG K SOTACK J ZIMMERMAN C HICKEY C ORME C SHOULSON I
Citation: A. Feigin et al., FUNCTIONAL DECLINE IN HUNTINGTONS-DISEASE, Movement disorders, 10(2), 1995, pp. 211-214
ON THE USE OF ARTIFICIAL REGRESSIONS IN CERTAIN MICROECONOMETRIC MODELS
Authors: ORME C
Citation: C. Orme, ON THE USE OF ARTIFICIAL REGRESSIONS IN CERTAIN MICROECONOMETRIC MODELS, Econometric theory, 11(2), 1995, pp. 290-305
SIMULATED CONDITIONAL MOMENT TESTS
Authors: ORME C
Citation: C. Orme, SIMULATED CONDITIONAL MOMENT TESTS, Economics letters, 49(3), 1995, pp. 239-245
EVIDENCE OF THE GLUTAMATE ANTAGONIST REMACEMIDE HYDROCHLORIDE IN HUNTINGTONS-DISEASE
Authors: KIEBURTZ K MCDERMOTT M MARSHALL FJ FEIGIN A COMO P ABWENDER D ZIMMERMAN C HICKEY C ORME C BORDWELL K SOTACK J GREENAMYRE JT DUNN C SHOULSON I
Citation: K. Kieburtz et al., EVIDENCE OF THE GLUTAMATE ANTAGONIST REMACEMIDE HYDROCHLORIDE IN HUNTINGTONS-DISEASE, Neurology, 45(4), 1995, pp. 254-254
STUDIES OF LARGE-SCALE UNSTABLE GROWTH FORMED DURING GAAS(001) HOMOEPITAXY
Authors: ORME C JOHNSON MD LEUNG KT ORR BG SMILAUER P VVEDENSKY D
Citation: C. Orme et al., STUDIES OF LARGE-SCALE UNSTABLE GROWTH FORMED DURING GAAS(001) HOMOEPITAXY, Journal of crystal growth, 150(1-4), 1995, pp. 128-135
INSTABILITIES IN MBE GROWTH
Authors: HUNT AW ORME C WILLIAMS DRM ORR BG SANDER LM
Citation: Aw. Hunt et al., INSTABILITIES IN MBE GROWTH, Europhysics letters, 27(8), 1994, pp. 611-616
THE SURFACE EVOLUTION AND KINETIC ROUGHENING DURING HOMOEPITAXY OF GAAS (001)
Authors: ORR BG JOHNSON MD ORME C SUDIJONO J HUNT AW
Citation: Bg. Orr et al., THE SURFACE EVOLUTION AND KINETIC ROUGHENING DURING HOMOEPITAXY OF GAAS (001), Solid-state electronics, 37(4-6), 1994, pp. 1057-1063
STABLE AND UNSTABLE GROWTH IN MOLECULAR-BEAM EPITAXY
Authors: JOHNSON MD ORME C HUNT AW GRAFF D SUDIJONO J SANDER LM ORR BG
Citation: Md. Johnson et al., STABLE AND UNSTABLE GROWTH IN MOLECULAR-BEAM EPITAXY, Physical review letters, 72(1), 1994, pp. 116-119
AN OPEN-LABEL TRIAL OF COENZYME-Q10 (COQ) IN HUNTINGTONS-DISEASE (HD)
Authors: FEIGIN A KIEBURTZ K COMO P ABWENDER D ZIMMERMAN C HICKEY C STEINBERG K BORDWELL K SOTACK J ORME C SHOULSON I
Citation: A. Feigin et al., AN OPEN-LABEL TRIAL OF COENZYME-Q10 (COQ) IN HUNTINGTONS-DISEASE (HD), Neurology, 44(4), 1994, pp. 10000397-10000398
MAGNETIC FORCE MICROSCOPY OF SINGLE-CRYSTAL MAGNETITE (FE3O4)
Authors: PROKSCH R FOSS S ORME C SAHU S MOSKOWITZ B
Citation: R. Proksch et al., MAGNETIC FORCE MICROSCOPY OF SINGLE-CRYSTAL MAGNETITE (FE3O4), Journal of applied physics, 75(10), 1994, pp. 6892-6892
INVESTIGATING GENERALIZATIONS OF EXPECTED UTILITY-THEORY USING EXPERIMENTAL-DATA
Authors: HEY JD ORME C
Citation: Jd. Hey et C. Orme, INVESTIGATING GENERALIZATIONS OF EXPECTED UTILITY-THEORY USING EXPERIMENTAL-DATA, Econometrica, 62(6), 1994, pp. 1291-1326
A CONTROLLED TRIAL OF LAZABEMIDE (RO-19-6327) IN LEVODOPA-TREATED PARKINSONS-DISEASE
Authors: KIEBURTZ K MCDERMOTT M SHOULSON I OAKES D FAHN S LANG A PENNEY JB RODNITZKY R SHULTS C TANNER C TETRUD J GORDON M LEWITT P BENNETT J KOLLER W FRIEDMAN JH KURLAN R OBRIEN C MARK MH WEINER WJ SANCHEZRAMOS J PAULSON G COMELLA C JANKOVIC J OLANOW W SHANNON K LEWIS P WINFIELD L CIECIERSKI K MISTURA K LANDOW E DIETRICH S GEBHARDT AM BARTER R KENNEDY D CULLEN KA GARDINER IF BERGEN M PATTERSON V FABRIELE M SHELDON C CORNELIUS L DUDTE K THELEN JA DUNNE C GAUGER L MALAPIRA T COURVILLE K TROTTER H PELUSIO RM RUDOLPH A CASACELI C MILLER C BOETTRICH C CONNORTON J BYRNE L ORME C BORDWELL K MCMANUS J SOTACK J RANDOLPH H KAVANAUGH B BAKER D RUMFOLA L NOBEL R EBERLY S PLUMB S WATTS A GERWITZ K DARCY S EVANS P FREDERICK D DELLAPENA L SINGLETARY V TARIOT P BELL E GRIGGS RC HALL WJ HERNDON R MARSDEN CD CHASE TN COHEN G FLEISS J JACOBS L MOSS AJ MELAMED E DORFLINGER E YOO K SHIMOUN G MORAWSKY L
Citation: K. Kieburtz et al., A CONTROLLED TRIAL OF LAZABEMIDE (RO-19-6327) IN LEVODOPA-TREATED PARKINSONS-DISEASE, Archives of neurology, 51(4), 1994, pp. 342-347
Risultati: 1-25 | 26-27